Jonathan L. Powell, MD
PhysicianFellowship
- Hematology/Oncology - The Children's Hospital of Philadelphia, 2004
Internship Residency
- Pediatrics - The Children's Hospital of Philadelphia, 2001
Medical/Dental School
- MD - University of Texas Southwestern Medical Center, 1998
Board Certifications
- American Board of Pediatrics/Hematology-Oncology
-
Successful Crizotinib-Targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma; Unknown Source; (2023).
View Full Publication -
Sporadic extranodal Rosai-Dorfman-Destombes disease treated with tocilizumab; Pediatric Blood & Cancer; (2022).
View Full Publication -
Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity; BMJ Case Reports; (2022).
View Full Publication -
Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1; JCO Precision Oncology; (2020).
View Full Publication -
A novel and successful therapeutic approach in the treatment of a patient with simultaneous relapsed Ewing sarcoma and therapy-related acute myeloid leukemia; Pediatric Blood & Cancer; (2020).
View Full Publication -
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain-of-function; Blood; (2020).
View Full Publication -
Topical Amphotericin B in Combination With Standard Therapy for Severe Necrotizing Skin and Soft-Tissue Mucormycosis in an Infant With Bilineal Leukemia; Journal of Pediatric Hematology/Oncology; (2014).
View Full Publication -
An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma; Bone Marrow Transplantation; (2004).
View Full Publication